Indivior Completes US Domestication, Adopts New Equity Plan with Significant Share Reserve

summarizeSummary

Indivior Pharmaceuticals, Inc. announced the completion of its U.S. domestication, becoming the ultimate parent company and exchanging all Indivior PLC shares for new U.S. common stock, alongside adopting a new omnibus equity incentive plan reserving 17.5 million shares.

check_boxKey Events

• U.S. Domestication Completed

  Indivior Pharmaceuticals, Inc., a Delaware corporation, has become the ultimate parent company, with Indivior PLC (England and Wales) becoming a wholly-owned subsidiary, effective January 23, 2026.

• Share Exchange and Continued Listing

  Indivior PLC ordinary shares were cancelled, and shareholders received one share of Indivior U.S. common stock for each share held. Indivior U.S. common stock began trading on Nasdaq under the existing 'INDV' ticker on January 26, 2026.

• New Equity Incentive Plan Adopted

  A 2026 Omnibus Equity Incentive Plan was adopted, reserving 17.5 million shares of common stock for future awards, representing a significant potential dilution.

• Corporate Governance Updates

  New Certificate of Incorporation and Bylaws were adopted, including standard anti-takeover provisions, and a Non-Employee Director Compensation Policy was established.

auto_awesomeAnalysis

The completion of the U.S. domestication marks a significant corporate restructuring for Indivior, shifting its domicile to the United States. While the direct share exchange maintains existing ownership, the adoption of a new equity incentive plan reserving 17.5 million shares represents a substantial potential future dilution for current shareholders. This amount is significant relative to the company's market capitalization. Additionally, the new corporate governance documents include anti-takeover provisions common for Delaware corporations, which could impact future shareholder activism. Investors should monitor the actual issuance of shares under the new equity plan and any further strategic implications of the domicile change.